NeuroImageHumansAlzheimer DiseaseMaleFemaleMagnetic Resonance Imaging
Multimodal integration of plasma biomarkers, MRI, and genetic risk to predict cerebral amyloid burden in Alzheimer's disease.
Yichen Wang, Hao-Jie Chen, Yuxin Cheng, YaoXin Xie, Yuyan Cheng, Shiyun Zhao, Yidong Jiang, Tianyu Bai, Yanxi Huo, Kexin Wang, Mingkai Zhang, Weijie Huang, Guozheng Feng, Ying Han, Ni Shu
Published: 202510.1016/j.neuroimage.2025.121550
Abstract
Alzheimer's disease (AD), the most prevalent neurodegenerative disorder, is marked by the accumulation of amyloid-β (Aβ) plaques. Although cerebral Aβ positron emission tomography (Aβ-PET) remains the gold standard for assessing cerebral Aβ burden, i…
Preview only. Read the full abstract at the source